Forbius Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 37

Employees

  • Latest Deal Type
  • M&A

Forbius General Information

Description

Operator of a protein engineering company intended to help design and develop biotherapeutics for the treatment of cancer and fibrotic diseases. The company is developing agents targeting the transforming growth factor-beta TGF-beta and epidermal growth factor receptor pathways, enabling doctors to have active inhibitors of validated pathways that have a differentiated mechanism of action.

Contact Information

Website
www.forbius.com
Formerly Known As
AvidBiologics, Formation Biologics
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 750 Boul. Saint-Laurent
  • Suite 101
  • Montreal, Quebec H2Y 2Z4
  • Canada
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Bristol-Myers Squibb
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 750 Boul. Saint-Laurent
  • Suite 101
  • Montreal, Quebec H2Y 2Z4
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Forbius Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Merger/Acquisition 21-Sep-2020 Completed Generating Revenue
10. Later Stage VC (Series C) 08-Oct-2019 Completed Clinical Trials - Phase 1
9. Grant 24-Aug-2018 Completed Clinical Trials - Phase 1
8. Later Stage VC 01-Jan-2018 Completed Clinical Trials - Phase 1
7. Later Stage VC (Series B) 15-May-2017 Completed Generating Revenue
6. Grant Completed Generating Revenue
5. Early Stage VC 25-Jun-2015 Completed Generating Revenue
4. Early Stage VC 01-Jan-2015 Completed Generating Revenue
3. Grant 01-Jan-2015 $12.8M Completed Generating Revenue
2. Early Stage VC 29-Sep-2014 Completed Generating Revenue
To view Forbius’s complete valuation and funding history, request access »

Forbius Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a protein engineering company intended to help design and develop biotherapeutics for the treatment of cance
Biotechnology
Montreal, Canada
37 As of 2020

Cambridge, MA
 

Oslo, Norway
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Forbius Competitors (43)

One of Forbius’s 43 competitors is Marengo Therapeutics, a Venture Capital-Backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Marengo Therapeutics Venture Capital-Backed Cambridge, MA
Nextera Venture Capital-Backed Oslo, Norway
Agenus Formerly VC-backed Lexington, MA
Centrose Venture Capital-Backed Madison, WI
Kite Pharma Formerly VC-backed Santa Monica, CA
You’re viewing 5 of 43 competitors. Get the full list »

Forbius Patents

  • 16

    Total Documents Applications and Grants

  • Total Patents Families

  • 6

    Granted

  • Pending

  • Expiring in next 12 mo

Forbius Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2965362-A1 Egfr antibody-based combination therapy Inactive 31-Oct-2014
EP-3223857-A1 Egfr antibody-based combination therapy Inactive 31-Oct-2014
EP-3223857-A4 Egfr antibody-based combination therapy Inactive 31-Oct-2014
US-20170333570-A1 Egfr antibody-based combination therapy Inactive 31-Oct-2014
WO-2016065456-A1 Egfr antibody-based combination therapy Inactive 31-Oct-2014 A61K47/6817
To view Forbius’s complete patent history, request access »

Forbius Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Forbius Former Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
BioCanRx Corporation
Cancer Prevention and Research Institute of Texas Government
HBM Healthcare Investments Venture Capital Minority
HBM Partners Venture Capital Minority
Innovation's Business Other Minority
You’re viewing 5 of 14 investors. Get the full list »

Ready to get started?

Request a free trial

Forbius FAQs

  • When was Forbius founded?

    Forbius was founded in 2011.

  • Where is Forbius headquartered?

    Forbius is headquartered in Montreal, Canada.

  • What is the size of Forbius?

    Forbius has 37 total employees.

  • What industry is Forbius in?

    Forbius’s primary industry is Biotechnology.

  • Is Forbius a private or public company?

    Forbius is a Private company.

  • What is Forbius’s current revenue?

    The current revenue for Forbius is .

  • How much funding has Forbius raised over time?

    Forbius has raised $5.95M.

  • Who are Forbius’s investors?

    BioCanRx, Cancer Prevention and Research Institute of Texas, HBM Healthcare Investments, HBM Partners, and Innovation's Business are 5 of 14 investors who have invested in Forbius.

  • Who are Forbius’s competitors?

    Marengo Therapeutics, Nextera, Agenus, Centrose, and Kite Pharma are some of the 43 competitors of Forbius.

  • When was Forbius acquired?

    Forbius was acquired on 21-Sep-2020.

  • Who acquired Forbius?

    Forbius was acquired by Bristol-Myers Squibb.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process